Infused with a powerful blend of hydrolyzed collagen and hyaluronic acid, the ILLUMIASKIN ALL 1N ONE Mask works wonders to lock in moisture and replenish your skin’s natural hydration levels. Indulge in this rich formula to achieve a restored, smooth, and supple complexion that radiates with youthful vitality. 

This mask includes salmon DNA, a remarkable component that works to support the rejuvenation and renewal of the skin, helping to restore its natural resilience and vibrant glow.  It also contains adenosine, which diminishes the appearance of ageing signs and energises the surface of your skin. Niacinamide, a multitasking ingredient, not only helps to soothe and calm the skin, but also evens out the skin’s texture and brightens overall complexion.

*Volume: 1 Box – 5 Pieces

How to use

Apply the ALL 1N ONE Mask on the face and leave it on for 10-20 minutes, for your skin to be deeply nourished. After removal, massage the excess serum into the skin or dab lightly with a tissue. For optimal results, we recommend incorporating this mask into your skincare routine on a weekly basis.

Key Ingredients

• Hydrolysed Collagen: improves skin elasticity and restore suppleness
• Hyaluronic Acid: locks moisture into the skin and reduces fine lines
• Salmon DNA: enhances skin repair and rejuvenates the skin
• Adenosine: decreases the appearance of wrinkles by energising the skin’s surface
• Niacinamide: improves the skin’s appearance and evens out skin tone and texture

Full Ingredients: Water, Butylene Glycol, Glycerin, Hydroxyacetophenone, Caprylyl Glycol, Dipropylene Glycol, Dipotassium Glycyrrhizate, Hydrolysed Collagen, Adenosine, Niacinamide, Sodium DNA, Sodium Hyaluronate, Biosaccharide Gum-1, Hydrogenated Lecithin, Squalane, Cetyl Ethylhexanoate, Ceramide NP, Cholesterol, Brassica Campestris (Rapeseed) Sterols, Macadamia Ternifolia Seed Oil, Stearic Acid, Oleic Acid, 1,2-Hexanediol, Allantoin, Betaine, Carbomer, Arginine, Xanthan Gum, Disodium EDTA, Ethylhexylglycerin, Tocopherol.

The post ALL 1N ONE Mask appeared first on Illumia Therapeutics.